144 related articles for article (PubMed ID: 26722435)
1. Inorganic pyrophosphatase (PPA1) is a negative prognostic marker for human gastric cancer.
Yang Y; Cai J; Yin J; Wang D; Bai Z; Zhang J; Wang K; Yu G; Zhang Z
Int J Clin Exp Pathol; 2015; 8(10):12482-90. PubMed ID: 26722435
[TBL] [Abstract][Full Text] [Related]
2. Expression of Inorganic Pyrophosphatase (PPA1) Correlates with Poor Prognosis of Epithelial Ovarian Cancer.
Li H; Xiao N; Li Z; Wang Q
Tohoku J Exp Med; 2017 Feb; 241(2):165-173. PubMed ID: 28202851
[TBL] [Abstract][Full Text] [Related]
3. Decreased LIPF expression is correlated with DGKA and predicts poor outcome of gastric cancer.
Kong Y; Zheng Y; Jia Y; Li P; Wang Y
Oncol Rep; 2016 Oct; 36(4):1852-60. PubMed ID: 27498782
[TBL] [Abstract][Full Text] [Related]
4. ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker.
Zhang M; Zhang C; Du W; Yang X; Chen Z
Clin Transl Oncol; 2016 Aug; 18(8):776-81. PubMed ID: 26527032
[TBL] [Abstract][Full Text] [Related]
5. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
Hu X; Huang Z; Liao Z; He C; Fang X
Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.
Jin Z; Jiang W; Jiao F; Guo Z; Hu H; Wang L; Wang L
Int J Clin Exp Pathol; 2014; 7(9):5872-9. PubMed ID: 25337229
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients.
Min L; Ruan Y; Shen Z; Jia D; Wang X; Zhao J; Sun Y; Gu J
Histopathology; 2015 Nov; 67(5):677-88. PubMed ID: 25809930
[TBL] [Abstract][Full Text] [Related]
8. UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma.
Yang H; Zhang C; Fang S; Ou R; Li W; Xu Y
Int J Clin Exp Pathol; 2015; 8(11):13957-67. PubMed ID: 26823707
[TBL] [Abstract][Full Text] [Related]
9. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
10. Activation of FOXO3a suggests good prognosis of patients with radically resected gastric cancer.
Yu S; Yu Y; Sun Y; Wang X; Luo R; Zhao N; Zhang W; Li Q; Cui Y; Wang Y; Li W; Liu T
Int J Clin Exp Pathol; 2015; 8(3):2963-70. PubMed ID: 26045805
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
12. New tumour antigen PLAC1/CP1, a potentially useful prognostic marker and immunotherapy target for gastric adenocarcinoma.
Liu F; Shen D; Kang X; Zhang C; Song Q
J Clin Pathol; 2015 Nov; 68(11):913-6. PubMed ID: 26157147
[TBL] [Abstract][Full Text] [Related]
13. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
Zhang L; Qiu M; Jin Y; Ji J; Li B; Wang X; Yan S; Xu R; Yang D
Int J Clin Exp Pathol; 2015; 8(9):11084-91. PubMed ID: 26617827
[TBL] [Abstract][Full Text] [Related]
14. Pyrophosphatase overexpression is associated with cell migration, invasion, and poor prognosis in gastric cancer.
Jeong SH; Ko GH; Cho YH; Lee YJ; Cho BI; Ha WS; Choi SK; Kim JW; Lee CW; Heo YS; Shin SH; Yoo J; Hong SC
Tumour Biol; 2012 Dec; 33(6):1889-98. PubMed ID: 22797819
[TBL] [Abstract][Full Text] [Related]
15. Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma.
Chang KK; Cho SJ; Yoon C; Lee JH; Park DJ; Yoon SS
Ann Surg Oncol; 2016 Dec; 23(13):4238-4246. PubMed ID: 27364501
[TBL] [Abstract][Full Text] [Related]
16. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of Siglec-8 associates with poor prognosis in patients with gastric cancer after surgical resection.
Cao Y; Liu H; Zhang H; Lin C; Li R; Zhang W; Shen Z; Xu J
Tumour Biol; 2016 Aug; 37(8):10883-91. PubMed ID: 26883254
[TBL] [Abstract][Full Text] [Related]
18. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of polycomb group protein expression in advanced gastric cancer.
Lee H; Yoon SO; Jeong WY; Kim HK; Kim A; Kim BH
Hum Pathol; 2012 Oct; 43(10):1704-10. PubMed ID: 22520951
[TBL] [Abstract][Full Text] [Related]
20. Activation of P21-activated protein kinase 2 is an independent prognostic predictor for patients with gastric cancer.
Gao C; Ma T; Pang L; Xie R
Diagn Pathol; 2014 Mar; 9():55. PubMed ID: 24621074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
